Umifenovir

Spotlight

CSIR’s Central Drug Research Institute (CDRI) Lucknow Gets Nod For Conducting Clinical Ttrials Of Antiviral Drug Umifenovir

June 19, 2020 09:15
Healthwire Bureau

The CSIR — Central Drug Research Institute (CDRI) Lucknow, has received permission for carrying out clinical trial of antiviral drug Umifenovir for treating coronavirus patients. The Phase III clinical trials…

View Post

Latest News
Spotlight

Glenmark To Commence Another New Phase 3 Clinical Trial On A Combination Of Two Anti-Viral Drugs Favipiravir And Umifenovir

May 26, 2020 14:06
Healthwire Bureau

Glenmark Pharmaceuticals Ltd Glenmark has announced to commence another new phase 3 Clinical Trial on a combination of two anti-viral drugs Favipiravir and Umifenovir in Hospitalized Patients of Moderate COVID-19…

View Post

Menu

Umifenovir

CSIR’s Central Drug Research Institute (CDRI) Lucknow Gets Nod For Conducting Clinical Ttrials Of Antiviral Drug Umifenovir

Glenmark To Commence Another New Phase 3 Clinical Trial On A Combination Of Two Anti-Viral Drugs Favipiravir And Umifenovir

Diabetes and Inflammation Linked to Accelerated Brain Aging and Higher Dementia Risk: Experts

Heart Muscle Regeneration Observed in Patients with Artificial Hearts, Study Finds

Flesh-Eating Ulcer Cases Surge in Australia: Health Authorities Issue Warning

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial

FDA Moves to Restrict Psychoactive Mushrooms Used in Edibles Amid Growing Concerns